Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Exact Sciences Offering $1B of Convertible Senior Notes

Exact Sciences Offering $1B of Convertible Senior Notes

Feb 24, 2020
|
staff reporter

This story has been updated with new information from the company on the size, value, and details of the offering.

NEW YORK – Exact Sciences announced after the close of the market on Monday that it has launched an underwritten public offering of $850 million of convertible senior notes due 2028, then priced and upsized the offering to $1 billion on Tuesday.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Changes to the Lancet's Process

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

Emails Show Pressure on CDC

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

Into One System

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

PLOS Papers on Dilated Cardiomyopathy, Lung Cancer Epigenetics, Pediatric Staphylococcus aureus Infections

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.

What's Popular?

In Business News

  1. Illumina to Acquire Grail for $8B in Cash and Stock

  2. Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider

    Premium

  3. Biocept Lung Cancer Liquid Biopsy Test Obtains Coverage From Blue Cross Affiliate Highmark

  4. Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

  5. Arna Genomics Raises $3.5M In Series A Financing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.